Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Leiomyosarcoma, drawn from the whole corpus: 6 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
No targeted or immune therapy works in most patients.
Uterine tumours are still discovered by accident after fibroid surgery.
Adjuvant chemotherapy remains unproven.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 8 changes by month →When this page itself was last checked or edited.
Median PFS 12.
A milestone in how this cancer is treated.
Abdominal recurrence-free survival not improved by preoperative radiotherapy; possible benefit in liposarcoma subgroups only.
Liposarcoma and leiomyosarcoma after anthracycline
A milestone in how this cancer is treated.